Eli Lilly said the treatment, a once-daily pill called muvalaplin, showed reductions in Lp (a) levels compared to placebo. Injectables are currently in Phase 3 development, but "these are the first ...
EliLilly (LLY) has recently been on Zacks.com's list of the most ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending ...
Some results have been hidden because they may be inaccessible to you